Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,497 | 99 | 97.8% |
| Education | $79.99 | 1 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $473.27 | 14 | $0 (2024) |
| GENZYME CORPORATION | $391.78 | 13 | $0 (2024) |
| Lilly USA, LLC | $368.61 | 17 | $0 (2023) |
| Arcutis Biotherapeutics, Inc. | $266.41 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $255.86 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $255.48 | 5 | $0 (2023) |
| Journey Medical Corporation | $239.05 | 2 | $0 (2022) |
| Incyte Corporation | $238.66 | 6 | $0 (2024) |
| PFIZER INC. | $184.63 | 5 | $0 (2023) |
| Almirall LLC | $143.19 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $452.59 | 8 | E.R. Squibb & Sons, L.L.C. ($120.48) |
| 2023 | $1,682 | 54 | Arcutis Biotherapeutics, Inc. ($249.20) |
| 2022 | $1,245 | 35 | Journey Medical Corporation ($239.05) |
| 2021 | $197.02 | 3 | Optinose US, Inc. ($109.23) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $115.21 | General |
| Category: IMMUNOLOGY | ||||||
| 02/22/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $98.25 | General |
| Category: DERMATOLOGY | ||||||
| 02/13/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.26 | General |
| Category: Dermatology | ||||||
| 01/30/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $21.58 | General |
| Category: DERMATOLOGY | ||||||
| 01/23/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Dermatology | ||||||
| 01/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $33.47 | General |
| Category: Immunology | ||||||
| 01/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $120.48 | General |
| Category: Immunology | ||||||
| 01/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Dermatology | ||||||
| 12/20/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $8.67 | General |
| 12/06/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Immunology | ||||||
| 11/28/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Immunology | ||||||
| 11/09/2023 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $21.87 | General |
| Category: DERMATOLOGY | ||||||
| 11/02/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Immunology | ||||||
| 10/31/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2023 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $98.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: Immunology | ||||||
| 10/19/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Dermatology | ||||||
| 10/10/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/05/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Immunology | ||||||
| 09/26/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $33.31 | General |
| Category: Immunology | ||||||
| 09/15/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Immunology | ||||||
| 09/12/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Immunology | ||||||
| 09/07/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Immunology | ||||||
| 08/30/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: Immunology | ||||||
| 08/24/2023 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $17.40 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 820 | 1,390 | $257,012 | $52,434 |
| 2022 | 16 | 479 | 726 | $122,195 | $41,253 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 186 | 278 | $46,982 | $14,519 | 30.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 95 | 127 | $38,100 | $8,045 | 21.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 100 | 100 | $35,500 | $5,935 | 16.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 132 | 191 | $34,571 | $5,434 | 15.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 76 | $18,924 | $5,331 | 28.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 75 | 83 | $21,041 | $4,179 | 19.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 14 | 14 | $11,536 | $2,637 | 22.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $10,615 | $1,878 | 17.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 90 | 444 | $22,200 | $1,677 | 7.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 11 | 11 | $5,225 | $1,098 | 21.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 21 | 29 | $4,894 | $853.47 | 17.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $7,425 | $848.98 | 11.4% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 64 | 134 | $20,712 | $11,574 | 55.9% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2022 | 45 | 69 | $10,137 | $5,469 | 54.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 65 | $10,985 | $3,700 | 33.7% |
| 99358 | Extended patient service without direct patient contact, first hour | Office | 2022 | 52 | 53 | $6,744 | $3,513 | 52.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 36 | 39 | $9,887 | $2,090 | 21.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $11,005 | $2,083 | 18.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 25 | 29 | $8,700 | $2,034 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $7,757 | $1,921 | 24.8% |
| 99350 | Established patient home visit, typically 1 hour | Office | 2022 | 16 | 16 | $3,258 | $1,838 | 56.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 13 | 14 | $6,650 | $1,492 | 22.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 17 | $4,233 | $1,391 | 32.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 40 | 45 | $8,145 | $1,345 | 16.5% |
| 99354 | Extended office or other outpatient service, first hour | Office | 2022 | 12 | 12 | $1,764 | $898.37 | 50.9% |
About Callie Powell, APRN
Callie Powell, APRN is a Registered Nurse healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/12/2011. The National Provider Identifier (NPI) number assigned to this provider is 1730457250.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Callie Powell, APRN has received a total of $3,577 in payments from pharmaceutical and medical device companies, with $452.59 received in 2024. These payments were reported across 100 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,497).
As a Medicare-enrolled provider, Powell has provided services to 1,299 Medicare beneficiaries, totaling 2,116 services with total Medicare billing of $93,687. Data is available for 2 years (2022–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Charleston, SC
- Active Since 12/12/2011
- Last Updated 06/30/2022
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1730457250
Products in Payments
- DUPIXENT (Biological) $420.69
- TALTZ (Drug) $368.61
- Sotyktu (Drug) $255.86
- OPZELURA (Drug) $238.66
- SKYRIZI (Biological) $221.50
- Cimzia (Drug) $135.02
- RINVOQ (Biological) $131.62
- TREMFYA (Drug) $130.49
- SIMPONI ARIA (Biological) $124.99
- AMELUZ (Drug) $124.03
- Xhance (Drug) $109.23
- Klisyri (Drug) $101.06
- LITFULO (Drug) $98.25
- VTAMA (Drug) $98.25
- EPSOLAY (Drug) $70.28
- CIBINQO (Drug) $66.11
- COSENTYX (Drug) $47.91
- ILUMYA (Biological) $44.86
- Seysara (Drug) $42.13
- LIBTAYO (Biological) $24.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Charleston
Rebecca Butcher, Fnp, Msn, FNP, MSN
Registered Nurse — Payments: $8,110
Molly White, Np, NP
Registered Nurse — Payments: $3,847
Kayla Adams, Np, NP
Registered Nurse — Payments: $2,820
Rachel Iulo, Dnp, Msn, Fnp-Bc, DNP, MSN, FNP-BC
Registered Nurse — Payments: $2,314
Lindsay Skaff, Fnp-Bc, FNP-BC
Registered Nurse — Payments: $1,666
Mrs. Julia Rodriguez, Aprn, APRN
Registered Nurse — Payments: $1,435